The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeller Regulatory News (KLR)

Share Price Information for Keller (KLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,066.00
Bid: 1,058.00
Ask: 1,062.00
Change: 20.00 (1.91%)
Spread: 4.00 (0.378%)
Open: 1,050.00
High: 1,066.00
Low: 1,036.00
Prev. Close: 1,046.00
KLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Mar 2022 13:59

KELLER GROUP PLC - Director/PDMR Shareholding

KELLER GROUP PLC - Director/PDMR Shareholding

PR Newswire

London, March 17

Keller Group plc (the “Company”)

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities (“PDMRs”)

Awards made under the Company’s Long-Term Incentive Plan (“LTIP”)

On 15 March 2022 the Company granted:

Deferred bonus share awards totalling 61,840 ordinary shares of 10p each in the Company (“Ordinary Shares”); and Performance share awards totalling 394,163 Ordinary Shares

The grant to the PDMRs listed in the tables below was approved by the Remuneration Committee under the terms of the LTIP and the Company was notified by the PDMRs on 17 March 2022. The transactions took place in the United Kingdom.

Deferred Bonus Share Award – in respect of the year ended 31 December 2021

Executive Directors are subject to a deferral of 25% of any annual bonus payment into Ordinary Shares for a period of two years. The deferred bonus share award retains eligibility for dividend equivalents from the date of grant until the vesting date. Malus and clawback apply.

NamePositionNo. of Ordinary Shares awarded1/3 Total Deferred Bonus Awards outstanding3
Michael SpeakmanChief Executive Officer24,68448,214
David BurkeChief Financial Officer16,20619,728

Other PDMRs are subject to a deferral into Ordinary Shares of any annual bonus payment in excess of 100% of salary. The deferral is also for a period of two years, with the deferred bonus share award retaining eligibility for dividend equivalents from the date of grant until the vesting date. Malus and clawback apply.

NamePositionNo. of Ordinary Shares awarded1/3 Total Deferred Bonus Awards outstanding3
Jim De WaelePresident, Europe1,9211,921
Eric DrooffPresident, North America5,6479,365
Venu RajuEngineering and Operations Director13,38227,440

Performance Share Award – for the period 2022/24

NamePositionNo. of Ordinary Shares awarded 1/2/3Total Performance Share Awards outstanding3
Michael SpeakmanChief Executive Officer112,990325,361
David BurkeChief Financial Officer61,820118,093
Graeme CookGroup People Director26,11174,156
Jim De WaelePresident, Europe29,67478,707
Eric DrooffPresident, North America35,669105,407
Kerry PorrittGroup Company Secretary and Legal Advisor22,76063,651
John RaineGroup HSEQ Director21,62363,694
Venu RajuEngineering and Operations Director29,535102,016
Katrina RocheChief Information Officer24,23446,293
Peter WytonPresident, AMEA29,74784,8774

The measures selected by the Remuneration Committee together with the associated targets are shown on the table below. The weightings are all set at 25% in order to provide balance between measures and materiality to each of them individually.

MeasureWeightingVesting Schedule
% of award that will vest
0%25%100%
Operating Profit Margin25%Below 5.5%5.5%6.5%
Cumulative EPS25%Below 330p330p400p
ROCE25%Below 12%12%18%
Relative TSR25%Below medianMedianUpper quartile

The Performance Share Award performance conditions are measured over a three year period ending on 31 December 2024, except for the Operating Profit Margin which is measured in year three. The Performance Share Award performance conditions are expected to vest in March 2025. Executive Directors are subject to a further two year holding period. Malus and clawback apply.

Enquiries:

Keller Group plcSilvana Glibota-Vigo, Group Head of SecretariatTel: 020 7616 7575

1 The price used to calculate the maximum number of Ordinary Shares under the Deferred Bonus Share Award and Performance Share Award was 781p, being the average closing price on 9, 10 and 11 March 2022 of the Company's shares on the main market of the London Stock Exchange.

2 The amounts shown above represent the maximum possible number of Ordinary Shares that may be granted to the above named participants under the 2022 Performance Share Award.

3 The awards above exclude notional dividends.

4 55,130 of these Performance Share Awards are rights to receive cash linked to share value and will, to the extent vested following the end of the performance period, be settled in cash.

LEI number: 549300QO4MBL43UHSN10Classification: 2.2 Inside information

Date   Source Headline
9th Apr 20243:45 pmPRNAnnual Financial Report
2nd Apr 20248:30 amPRNTotal Voting Rights
25th Mar 20242:45 pmPRNHolding(s) in Company
20th Mar 202410:35 amPRNDirector/PDMR Shareholding
12th Mar 20244:19 pmPRNDirector/PDMR Shareholding
8th Mar 20242:58 pmPRNHolding(s) in Company
7th Mar 202411:39 amPRNDirector/PDMR Shareholding - Correction
7th Mar 20249:50 amPRNDirector/PDMR Shareholding
5th Mar 20247:00 amRNSPreliminary Results for the year ended 31 Dec 2023
1st Mar 20248:30 amPRNTotal Voting Rights
15th Feb 20247:00 amPRNDirectorate Change and Director Declaration
1st Feb 20248:30 amPRNTotal Voting Rights
17th Jan 20247:00 amRNSPost Close Trading Update
2nd Jan 20249:39 amPRNTotal Voting Rights
2nd Jan 20248:30 amPRNBlocklisting - Interim Review
1st Dec 20238:30 amPRNTotal Voting Rights
15th Nov 20237:00 amPRNDirectorate Change - Non-executive Director Appointment
1st Nov 20238:30 amPRNTotal Voting Rights
23rd Oct 20237:00 amRNSTrading Update
2nd Oct 202310:53 amPRNTotal Voting Rights
25th Sep 20239:16 amPRNDirector Declaration
14th Sep 20234:18 pmPRNDirector/PDMR Shareholding
1st Sep 20238:00 amPRNTotal Voting Rights
1st Aug 202310:00 amPRNTotal Voting Rights
1st Aug 20237:00 amRNSInterim Results for the half year ended 30 June 23
5th Jul 20237:00 amRNSTrading Update
3rd Jul 20238:30 amPRNBlocklisting - Interim Review
3rd Jul 20238:30 amPRNTotal Voting Rights
29th Jun 202310:02 amPRNDirector/PDMR Shareholding
23rd Jun 20232:07 pmPRNHolding(s) in Company
17th May 20237:00 amRNSAGM Trading Update
7th Mar 20237:00 amRNSUnaudited Preliminary Results
9th Jan 20237:00 amRNSAustral financial reporting fraud & trading update
28th Dec 20226:15 pmRNSHomeserve
17th Nov 20227:00 amRNSTrading Update
22nd Sep 202211:00 amRNSSite visit and proven recession resilience
2nd Aug 20227:00 amRNSInterim Results for the half year ended 26 June 22
27th Jun 20227:00 amRNSNew Contract, Trading Update & Strategic Progress
1st Jun 20228:00 amPRNTotal Voting Rights
26th May 20222:00 pmRNSSite visit and proven recession resilience
18th May 20227:00 amRNSAGM Trading Update
12th Apr 20224:06 pmPRNHolding(s) in Company
12th Apr 20224:01 pmPRNAnnual Financial Report
1st Apr 20227:00 amPRNTotal Voting Rights
17th Mar 20221:59 pmPRNDirector/PDMR Shareholding
10th Mar 20223:23 pmPRNDirector/PDMR Shareholding
8th Mar 20227:00 amRNSPreliminary Results for the year ended 31 Dec 21
1st Mar 20227:00 amPRNTotal Voting Rights
1st Feb 20227:00 amPRNDirectorate Change
1st Feb 20227:00 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.